Involvement of anoikis-resistance in the metastasis of hepatoma cells

Experimental Cell Research

Volumn 315, Issue 7, 2009, Pages 1148-1156

  Cao, Lili ^a,b   Han, Lihui ^a   Zhang, Zhiyong ^a   Li, Jie ^b   Qu, Zhonghua ^a   Du, Juan ^b   Liang, Xiaohong ^a   Liu, Yugang ^a   Liu, Hua ^a   Shi, Yongyu ^a   Liu, Suxia ^a   Gao, Lifen ^a   Sun, Wensheng ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Anoikis; Apoptosis; Cancer; Metastasis; TRAIL

Indexed keywords

TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANOIKIS; ARTICLE; CANCER CELL; CANCER INVASION; CELL AGGREGATION; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; DOWN REGULATION; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; METASTASIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; WESTERN BLOTTING;

ANOIKIS; CARCINOMA, HEPATOCELLULAR; CASPASES; CELL ADHESION; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 63049115104     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.11.010     Document Type: Article

References (30)

1. Frisch S.M., and Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124 (1994) 619-626
2. C.D. Simpson, K. Anyiwe, A.D. Schimmer, Anoikis resistance and tumor metastasis, Cancer Lett. 272 (2008) 177-185.
3. Kodama K., Ishii G., Miyamoto S., Goya M., Zhang S.C., Sangai T., Yoshikawa T., Hasebe T., Hitomi Y., Izumi K., and Ochiai A. Laminin 5 expression protects against anoikis at aerogenous spread and lepidic growth of human lung adenocarcinoma. Int. J. Cancer 116 (2005) 876-884
4. Wei L., Yang Y., Zhang X., and Yu Q. Anchorage-independent phosphorylation of p130(Cas) protects lung adenocarcinoma cells from anoikis. J. Cell Biochem. 87 (2002) 439-449
5. Wei L., Yang Y., Zhang X., and Yu Q. Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene 23 (2004) 9052-9061
6. Zeng Q., Chen S., You Z., Yang F., Carey T.E., Saims D., and Wang C.Y. Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B. J. Biol. Chem. 277 (2002) 25203-25208
7. Swan E.A., Jasser S.A., Holsinger F.C., Doan D., Bucana C., and Myers J.N. Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer. Oral Oncol. 39 (2003) 648-655
8. Diaz-Montero C.M., and McIntyre B.W. Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents. BMC Cancer 5 (2005) 39
9. Berezovskaya O., Schimmer A.D., Glinskii A.B., Pinilla C., Hoffman R.M., Reed J.C., and Glinsky G.V. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res. 65 (2005) 2378-2386
10. Hasanuzzaman M., Kutner R., Agha-Mohammadi S., Reiser J., and Sehgal I. A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines. Mol. Cancer 6 (2007) 34
11. Derksen P.W., Liu X., Saridin F., van der Gulden H., Zevenhoven J., Evers B., van Beijnum J.R., Griffioen A.W., Vink J., Krimpenfort P., Peterse J.L., Cardiff R.D., Berns A., and Jonkers J. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10 (2006) 437-449
12. Minard M.E., Ellis L.M., and Gallick G.E. Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clin. Exp. Metastasis 23 (2006) 301-313
13. Zhu Z., Sanchez-Sweatman O., Huang X., Wiltrout R., Khokha R., Zhao Q., and Gorelik E. Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res. 61 (2001) 1707-1716
14. Zhang Z., Cao L., Li J., Liang X., Liu Y., Liu H., Du J., Qu Z., Cui M., Liu S., Gao L., Ma C., Zhang L., Han L., and Sun W. Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells. Cancer Lett. 267 (2008) 106-115
15. Loberg R.D., Fridman Y., Pienta B.A., Keller E.T., McCauley L.K., Taichman R.S., and Pienta K.J. Detection and isolation of circulating tumor cells in urologic cancers: a review. Neoplasia 6 (2004) 302-309
16. Sullivan R., and Graham C.H. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev. 26 (2007) 319-331
17. Frisch S.M. Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis. Curr. Biol. 9 (1999) 1047-1049
18. Derouet M., Wu X., May L., Hoon Yoo B., Sasazuki T., Shirasawa S., Rak J., and Rosen K.V. Acquisition of anoikis resistance promotes the emergence of oncogenic K-ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo. Neoplasia 9 (2007) 536-545
19. Geiger T.R., and Peeper D.S. Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis. Cancer Res. 67 (2007) 6221-6229
20. Zhang Y., Lu H., Dazin P., and Kapila Y. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. J. Biol. Chem. 279 (2004) 48342-48349
21. Goldberg G.S., Jin Z., Ichikawa H., Naito A., Ohki M., El-Deiry W.S., and Tsuda H. Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikis. Cancer Res. 61 (2001) 1334-1337
22. Laguinge L.M., Samara R.N., Wang W., El-Deiry W.S., Corner G., Augenlicht L., Mishra L., and Jessup J.M. DR5 receptor mediates anoikis in human colorectal carcinoma cell lines. Cancer Res. 68 (2008) 909-917
23. Martinez-Lorenzo M.J., Anel A., Alava M.A., Pineiro A., Naval J., Lasierra P., and Larrad L. The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Possible contribution to tumor counterattack. Exp. Cell Res. 295 (2004) 315-329
24. Ryan A.E., Shanahan F., O'Connell J., and Houston A.M. Fas ligand promotes tumor immune evasion of colon cancer in vivo. Cell Cycle 5 (2006) 246-249
25. Houston A., and O'Connell J. The Fas signalling pathway and its role in the pathogenesis of cancer. Curr. Opin. Pharmacol. 4 (2004) 321-326
26. Giovarelli M., Musiani P., Garotta G., Ebner R., Di Carlo E., Kim Y., Cappello P., Rigamonti L., Bernabei P., Novelli F., Modesti A., Coletti A., Ferrie A.K., Lollini P.L., Ruben S., Salcedo T., and Forni G. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. J. Immunol. 163 (1999) 4886-4893
27. Baetu T.M., and Hiscott J. On the TRAIL to apoptosis. Cytokine Growth Factor Rev. 13 (2002) 199-207
28. Gomez-Benito M., Martinez-Lorenzo M.J., Anel A., Marzo I., and Naval J. Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L/TRAIL. Exp. Cell Res. 313 (2007) 2378-2388
29. Truneh A., Sharma S., Silverman C., Khandekar S., Reddy M.P., Deen K.C., McLaughlin M.M., Srinivasula S.M., Livi G.P., Marshall L.A., Alnemri E.S., Williams W.V., and Doyle M.L. Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor. J. Biol. Chem. 275 (2000) 23319-23325
30. Clancy L., Mruk K., Archer K., Woelfel M., Mongkolsapaya J., Screaton G., Lenardo M.J., and Chan F.K. Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18099-18104